ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 1 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $0 | -100.0% | 568 | +7.8% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 527 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 527 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 527 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | -50.0% | 527 | 0.0% | 0.00% | – |
| Q3 2017 | $2,000 | 0.0% | 527 | 0.0% | 0.00% | – |
| Q2 2017 | $2,000 | 0.0% | 527 | 0.0% | 0.00% | – |
| Q1 2017 | $2,000 | 0.0% | 527 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | 0.0% | 527 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | – | 527 | +584.4% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 77 | -99.0% | 0.00% | – |
| Q1 2016 | $38,000 | +18.8% | 7,973 | 0.0% | 0.00% | – |
| Q4 2015 | $32,000 | +68.4% | 7,973 | +58.2% | 0.00% | – |
| Q3 2015 | $19,000 | -17.4% | 5,041 | 0.0% | 0.00% | – |
| Q2 2015 | $23,000 | -42.5% | 5,041 | -16.6% | 0.00% | – |
| Q1 2015 | $40,000 | – | 6,041 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 3,699,848 | $12,579,000 | 2.40% |
| Northeast Financial Consultants Inc | 732,265 | $2,490,000 | 1.04% |
| Family Management Corp | 41,008 | $139,000 | 0.10% |
| TFS CAPITAL LLC | 16,381 | $56,000 | 0.02% |
| WEDBUSH SECURITIES INC | 18,698 | $64,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 148,054 | $503,000 | 0.01% |
| THRIVENT FINANCIAL FOR LUTHERANS | 413,278 | $1,405,000 | 0.01% |
| CSS LLC/IL | 24,000 | $82,000 | 0.01% |
| SIMPLEX TRADING, LLC | 17,271 | $58,000 | 0.00% |
| CSS LLC/IL | 14,000 | $48,000 | 0.00% |